LabCompass
Mid career · publishing since 2003

Publications

15

Citations

174

Est. group size

Recurring co-author estimate

Active years

24

Publishing since 2003

Research summary
AI-generated

Aki Inase's research focuses on understanding and overcoming drug resistance in leukemia treatment, particularly involving antibody-drug conjugates like gemtuzumab ozogamicin, a targeted cancer therapy that delivers toxic agents directly to leukemia cells. The work examines how combining this drug with other inhibitors (targeting cellular pathways like mTOR and GSK3) can improve its cancer-killing effects by disrupting the mechanisms leukemia cells use to resist treatment. This research sits at the intersection of cancer biology, pharmacology, and cell biology.

Antibody-drug conjugatesLeukemia treatment resistanceTargeted cancer therapyCell signaling and apoptosis pathwaysLysosomal function in cancer cells

Publications have been sparse and irregular over the last decade, with several gap years followed by a recent uptick in 2025-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.8/year recently
172018: 1 publication182019: 1 publication1920212022: 1 publication2223242025: 1 publication252026: 2 publications226
Publishes in
  • International Journal of Hematology×1
  • eJHaem×1
  • Leukemia Research×1
  • The Oncologist×1
  • Regular and Young Investigator Award Abstracts×1
Similar researchers
By research-topic overlap
  • Millie M. Georgiadis

    Biochemistry, Genetics and Molecular Biology · Indiana University

  • Austin T. Raper

    Biochemistry, Genetics and Molecular Biology · The Ohio State University

  • A. Richard Morgan

    Biochemistry, Genetics and Molecular Biology · Indiana University

  • Clement Lin

    Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette

  • Danzhou Yang

    Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile